Evidence map›Paper›PMID 37759271›Full record

ArticleBMC infectious diseases2023

Impact of non-pharmaceutical interventions during COVID-19 on future influenza trends in Mainland China.

Xiaofan Liu, Ying Peng, Zhe Chen, Fangfang Jiang, Fang Ni, Zhiyong Tang, Xun Yang, Cheng Song, Mingli Yuan, Zhaowu Tao and 8 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in BMC infectious diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 3 countries.

Xiaofan Liu *Department of Pulmonary and Critical Care Medicine, Tongji Medical College, The Central Hospital of Wuhan, Huazhong University of Science and Technology, Wuhan, 430014, Hubei, China.
Ying Peng *Wuhan Centers for Disease Control and Prevention, Wuhan, 430024, Hubei, China.
Zhe Chen *Biological Sciences, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, SO17 1BJ, UK.
Fangfang Jiang *Department of Biostatistics, University of Iowa, Iowa City, IA, 52242, USA.
Fang Ni *Department of Pulmonary and Critical Care Medicine, Tongji Medical College, The Central Hospital of Wuhan, Huazhong University of Science and Technology, Wuhan, 430014, Hubei, China.
Zhiyong TangBiological Sciences, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, SO17 1BJ, UK.
Xun YangDepartment of Pulmonary and Critical Care Medicine, Tongji Medical College, The Central Hospital of Wuhan, Huazhong University of Science and Technology, Wuhan, 430014, Hubei, China.
Cheng SongDepartment of Pulmonary and Critical Care Medicine, Tongji Medical College, The Central Hospital of Wuhan, Huazhong University of Science and Technology, Wuhan, 430014, Hubei, China.
Mingli YuanDepartment of Pulmonary and Critical Care Medicine, Tongji Medical College, The Central Hospital of Wuhan, Huazhong University of Science and Technology, Wuhan, 430014, Hubei, China.
Zhaowu TaoDepartment of Pulmonary and Critical Care Medicine, Tongji Medical College, The Central Hospital of Wuhan, Huazhong University of Science and Technology, Wuhan, 430014, Hubei, China.
Junjie XuDepartment of Pulmonary and Critical Care Medicine, Tongji Medical College, The Central Hospital of Wuhan, Huazhong University of Science and Technology, Wuhan, 430014, Hubei, China.
Ying WangDepartment of Pulmonary and Critical Care Medicine, Tongji Medical College, The Central Hospital of Wuhan, Huazhong University of Science and Technology, Wuhan, 430014, Hubei, China.
Qiong QianDepartment of Pulmonary and Critical Care Medicine, Tongji Medical College, The Central Hospital of Wuhan, Huazhong University of Science and Technology, Wuhan, 430014, Hubei, China.
Rob M EwingBiological Sciences, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, SO17 1BJ, UK.
Ping YinDepartment of Epidemiology and Biostatistics, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430014, China. pingyin2000@126.com.
Yi HuDepartment of Pulmonary and Critical Care Medicine, Tongji Medical College, The Central Hospital of Wuhan, Huazhong University of Science and Technology, Wuhan, 430014, Hubei, China. huyi@zxhospital.com.
Weihua WangDepartment of Pulmonary and Critical Care Medicine, Tongji Medical College, The Central Hospital of Wuhan, Huazhong University of Science and Technology, Wuhan, 430014, Hubei, China. drwang6610@163.com.
Yihua WangBiological Sciences, Faculty of Environmental and Life Sciences, University of Southampton, Southampton, SO17 1BJ, UK. yihua.wang@soton.ac.uk.
Central Hospital of Wuhan · CNHuazhong University of Science and Technology · CNUniversity of Southampton · GBUniversity of Iowa · USWuhan Center for Disease Control and Prevention · CN

Funding

Medical Research Council MR/S025480/1
6 · The paper itself

Abstract

backgroundInfluenza is a common illness for its high rates of morbidity and transmission. The implementation of non-pharmaceutical interventions (NPIs) during the COVID-19 pandemic to manage its dissemination could affect the transmission of influenza.

methodsA retrospective analysis, between 2018 and 2023, was conducted to examine the incidence of influenza virus types A and B among patients in sentinel cities located in North or South China as well as in Wuhan City. For validations, data on the total count of influenza patients from 2018 to 2023 were collected at the Central Hospital of Wuhan, which is not included in the sentinel hospital network. Time series methods were utilized to examine seasonal patterns and to forecast future influenza trends.

resultsNorthern and southern cities in China had earlier outbreaks during the NPIs period by about 8 weeks compared to the 2018-2019. The implementation of NPIs significantly reduced the influenza-like illness (ILI) rate and infection durations. Influenza B Victoria and H3N2 were the first circulating strains detected after the relaxation of NPIs, followed by H1N1 across mainland China. The SARIMA model predicted synchronized H1N1 outbreak cycles in North and South China, with H3N2 expected to occur in the summer in southern cities and in the winter in northern cities over the next 3 years. The ILI burden is expected to rise in both North and South China over the next 3 years, with higher ILI% levels in southern cities throughout the year, especially in winter, and in northern cities mainly during winter. In Wuhan City and the Central Hospital of Wuhan, influenza levels are projected to peak in the winter of 2024, with 2 smaller peaks expected during the summer of 2023.

conclusionsIn this study, we report the impact of NPIs on future influenza trends in mainland China. We recommend that local governments encourage vaccination during the transition period between summer and winter to mitigate economic losses and mortality associated with influenza.

Indexed as

COVID-19Influenza A Virus, H1N1 SubtypeInfluenza, HumanChinaHumansInfluenza A Virus, H3N2 SubtypePandemicsRetrospective StudiesCOVID-19ForecastInfluenzaNon-pharmaceutical interventionsSARIMA modelSeasonal decompositionSTL modelTime series methods

Identifiers

PMID37759271
PMCPMC10523625
OpenAlexW4387104743

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.